Project Grant HT94252310765
Award Date 8/1/23
Completion Date 7/31/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $539,904 to the President and Fellows of Harvard College, specifically the Harvard T.H. Chan School of Public Health, to conduct research on "Genomically Informed Morphological Stromal Signatures to Predict Lethal Prostate Cancer". The 3-year project, running from June 15, 2025 to June 14, 2028, aims to develop innovative methodological approaches...
- This $676,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a research initiative led by Harvard University to develop data-driven biomarker-informed decision analytics to improve the efficacy and reduce the toxicity of immune checkpoint blockade therapy for melanoma patients. The 3-year project aims to leverage advanced analytics and biomarker data to optimize the use of this cutting-edge cancer...
- This $1,014,000 project grant from the Defense Health Agency will fund research into targeted therapeutic opportunities for ovarian clear cell, small cell, and endometrioid carcinomas at President And Fellows of Harvard College from May 1, 2023 to April 30, 2027. The grant falls under the Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions. Through this...
- This Project Grant award of $676,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by President and Fellows of Harvard College (Harvard Medical School) to develop HUWE1 as a therapeutic target for treating mesothelioma. The project aims to advance the understanding and treatment of this rare and aggressive form of cancer, with an anticipated completion date of June 30, 2027. This award represents an...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,352,000.00 to President and Fellows of Harvard College, doing business as Harvard Medical School, to conduct targeted therapy development through spatial molecular profiling for rare pediatric and adult brain tumors using limited tissue samples. The project aims to transform healthcare for military service members, veterans, and the broader public by...
- The Defense Health Agency has awarded a $657,263 project grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (d.b.a. DFCI) in Boston, MA. The award, effective September 1, 2024 through August 31, 2027, will support DATA-DRIVEN BIOMARKER-INFORMED DECISION ANALYTICS IN MELANOMA: IMPROVING EFFICACY AND REDUCING TOXICITY OF IMMUNE CHECKPOINT BLOCKADE. Through this grant, DFCI will conduct research to develop data-driven...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $397,510.00 to The Leland Stanford Junior University (Stanford University) to conduct research on "REVEALING AND TARGETING LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA". The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research, with a focus on cancer therapies. The award...
- The federal Project Grant award for "REGULATION OF STEROID HORMONE SIGNALING AND LIPID METABOLISM BY THE TUBEROUS SCLEROSIS COMPLEX" is provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $254,233 award to President and Fellows of Harvard College, doing business as Harvard Medical School, will support advanced biomedical research to investigate the mechanisms of steroid hormone signaling and lipid metabolism regulated...
- The Department of the Army Medical Command awarded a $825,247 Project Grant to President and Fellows of Harvard College through the Military Medical Research and Development program (CFDA 12.420) to support research titled "Improving the Durability of Immunological Memory During Anti-PD-1 Immunotherapy" from September 1, 2022 to August 31, 2025. The grant will fund research at Harvard Medical School in Boston, MA to investigate medical solutions for enhancing long-term immune responses...
- The federal Project Grant award in the amount of $178,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding research at the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts to target the Merkel ST-MYCL-EP400 complex in Merkel cell carcinoma. The research aims to develop innovative approaches to the understanding, detection, and treatment of this rare and aggressive form of skin cancer...